Ignite Creation Date:
2024-05-06 @ 7:07 PM
Last Modification Date:
2024-10-26 @ 3:01 PM
Study NCT ID:
NCT05908409
Status:
RECRUITING
Last Update Posted:
2023-09-28
First Post:
2023-05-03
Brief Title:
A Phase 12 Study of IDP-121 in Patients With RelapsedRefractory Hematologic Malignancies
Sponsor:
IDP Discovery Pharma SL
Organization:
IDP Discovery Pharma SL
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Multiple Myeloma MM |
| Diffuse Large B-Cell Lymphoma Not Otherwise Specified |
| Double Hit Lymphoma |
| High Grade B-Cell Lymphoma Not Otherwise Specified |
| Chronic Lymphocytic Leukemia CLL |
| Triple Hit Lymphoma |
Keywords: